Medcann Industries, Inc. (OTCPK:NSRS) entered into a definitive agreement to acquire a 80% stake in Freedom Holdings, Inc. (OTCPK:FHLD) for $0.05 million on January 26, 2023. Medcann is to purchase 40,000,000 restricted shares of Freedom at $0.00125 per share. Brian Kistler, CEO of Freedom Holdings, Inc. shall resign all Officer/Director positions only to serve as an advisor for a period of 2 years to insure a smooth transition and John Vivian, CEO of Medcann shall simultaneously be appointed as the Chairman and CEO of Freedom.

Medcann as the parent company shall assume the debt and ongoing operational costs of Freedom.